LDS/Medical Tests/Follicle Stimulating Hormone (FSH)

Follicle Stimulating Hormone (FSH)

Follicle-stimulating hormone (FSH) is a glycoprotein secreted by the anterior pituitary gland. The structure for FSH is similar to LH, TSH, and hCG as the alpha portion of the molecules are identical. The beta portion is what differs in all. Production of the FSH molecule is regulated by hypothalamic gonadotropin releasing hormone (GnRH) and feedback from gonadal steroid hormones. FSH and LH belong to the gonadotropin family, and synergistically regulate and stimulate the growth and function of male and female sex organs. In the female, FSH stimulates follicular growth, prepares ovarian follicles for luteinizing hormone (LH) activity, and enhances the LH-induced release of estrogen. Testing for both FSH and LH are useful in the diagnosis, management, and treatment of infertility in both genders. After menopause, decreased ovarian estradiol secretion results in increased FSH and LH levels. Because of this, increased FSH levels are associated with menopause. Increased levels can also be associated with primary ovarian hypofunction in females, and primary hypogonadism in males. Increased levels during the childbearing years are considered an abnormal disease state. Abnormal FSH levels with corresponding increased or decreased levels of LH, estrogens, progesterone, and testosterone are associated with a number of pathological conditions. In the male, FSH stimulates seminiferous tubule and testicular growth and is involved in the early stages of spermatogenesis. Primary testicular failure results in increased FSH and LH levels. Decreased FSH levels are associated with primary ovarian hyperfunction in females, and primary hypergonadism in males and/or are indicative of pituitary or hypothalamic dysfunction. Normal or decreased FSH levels are associated with polycystic ovary disease in females.

  • Diagnosis of male and female hypogonadism or gonadal insufficiency
  • Pituitary function test to distinguish primary gonadal failure from secondary (hypothalamic/pituitary) causes of menstrual disturbance and amenorrhea
  • To define menstrual cycle phases in infertility evaluation of women and men
  • Diagnosis, management and treatment of infertility in women and men

Increased in:

  • Primary gonadal failure
  • Ovarian or testicular agenesis
  • Turner's Syndrome
  • Castration and Anorchia (Testicular Agenesis in male)
  • Postmenopause
  • Klinefelter syndrome

Decreased in:

  • Hypothalamic disorders
  • Adrenal or Ovarian Neoplasm
  • Polycystic Ovarian Disease
  • Pituitary disorders
  • Pregnancy
  • Some drugs such as corticosteroids, oral contraceptives, estrogens, testosterones

Unit: mU/mL or U/L

Prepubertal Child
Group mU/mL or U/L
2–11 mo Male 0.19–11.3
2–11 mo Female 0.10–11.3
1–10 yr Male 0.3–4.6
1–10 yr Female 0.68–6.7

 

Puberty (by Tanner Stage)
Stage / Sex mU/mL or U/L
Stage 1–2 Male 0.30–4.6
Stage 1–2 Female 0.68–6.7
Stage 3–4 Male 1.24–15.4
Stage 3–4 Female 1.0–7.4
Stage 5 Male 1.53–6.8
Stage 5 Female 1.0–9.2

 

Adults
Group mU/mL or U/L
Adult Male 1.42–15.4
Female, Follicular phase 1.37–9.9
Female, Ovulatory peak 6.17–17.2
Female, Luteal phase 1.09–9.2
Female, Postmenopausal 19.3–100.6

Immunochemilumonmetric assay, Immunoassay, Enzyme-Linked Immunosorbent Assay (ELISA). 

Serum (SST). 

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Luteinizing Hormone (LH), Estrogens, Progesterone, Testosterone (free and total), Gonadotropin Releasing Hormone (GnRH), Estradiol.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login